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Abstract: 
Studies suggest iodinated contrast media (ICM) may increase organ dose and blood cell DNA damage 
for a given x-ray exposure. The impact of ICM on dose/damage to extravascular cells and cancer risks 
is unclear. Methods: We used Monte Carlo modelling to investigate the microscopic distribution of 
absorbed dose outside the lumen of arteries, capillaries and interstitial fluids containing blood and 
various concentrations of iodine. Models were irradiated with four x-ray spectra representing clinical 
procedures. Results: For the artery model, The average dose enhancement factors (DEF) to blood 
were 1.70, 2.38, 7.38, and 12.34 for mass concentrations of iodine in blood (ρiI) of 5, 10, 50 and 100 
mg/ml, respectively, compared to 0 mg/ml. Average DEFs were reduced to 1.26, 1.51, 3.48 and 5.56, 
respectively, in the first micrometre of the vessel wall, falling to 1.01, 1.02, 1.06 and 1.09 at 40-50 μm 
from the lumen edge. For the capillary models, DEF for extravascular tissues was on average 48% 
lower than DEF for the whole model, including capillaries. A similar situation was observed for the 
interstitial model, with DEF to the cell nucleus being 35% lower than DEF for the whole model. 
Conclusions: While ICM may modify the absorbed doses from diagnostic x-ray examinations, the 
effect is smaller than suggested by assays of circulating blood cells or blood dose enhancement. 
Conversely, the potentially large increase in dose to the endothelium of blood vessels means that 
macroscopic organ doses may underestimate the risk of radiation induced cardiovascular disease for 
ICM-enhanced exposures.  
Key words: Contrast media; radiation doses; radiation protection 
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Abbreviations:  
ICM = iodinated contrast media 
DEFICM = Dose enhancement factor due to ICM 
Introduction: 
Iodinated contrast media (ICM) are frequently used in diagnostic x-ray imaging, including around 
50% of CT scans [1], to improve visualization of blood vessels and other structures. In addition to 
well-known chemo/osmotoxic side effects, including allergic reactions and kidney damage [2], 
concerns have also been raised that contrast media may increase cancer risks from x-ray exposures [3, 
4]. Recently, we reviewed around four decades-worth of research investigating the radiation doses and 
associated DNA damage for ICM-enhanced, versus unenhanced x-ray exposures [5]. Increased DNA 
damage is likely to be a dosimetric effect, due to ICM molecules acting as a source of secondary 
radiation, i.e. photoelectrons, Auger electrons and photons. To date, all DNA damage assays have 
focused on cells in the blood itself, i.e. lymphocytes. While a clear suggestion of increased blood cell 
DNA damage for ICM-enhanced exposures was apparent (typically 30-100%, though up to 267%), it 
is unclear if these findings also imply an increased risk of developing cancer. In particular, it is not 
clear if the presence of iodine in blood vessels leads to DNA damage in extravascular cells, including 
those cells prone to malignant transformation.  
Few studies investigating the dosimetric impact of ICM on tissues other than the blood in diagnostic 
x-ray imaging have been published [6-10]. These have generally focused on macroscopic doses, i.e. 
the mean absorbed dose to whole organs or phantoms, without assessing the microscopic pattern of 
energy deposition under ICM-enhanced conditions. As the dose perturbation effects of high Z 
elements are extremely close range (typically within a few tens of micrometres) [11], it may be 
possible for ICM to increase blood dose and macroscopic organ doses quite markedly with little 
impact on dose to cells outside blood vessels. To investigate this, and to help place blood cell DNA 
damage assays in context, we performed a microdosimetric analysis using the Monte Carlo code 
MCNP6.1 and two simple blood vessel models. The aim of the study was to investigate ICM-
associated enhancement of dose as a function of distance from the blood itself, for various 
concentrations of iodine in the blood and various beam spectra used in clinical x-ray imaging. 
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Methods: 
Three models were constructed. The first represented a single 5 cm long artery (Figure 1) with radial 
dimensions typical of a coronary artery in a normal individual, based on previously published data 
[12-14]. The radius of the artery lumen was initially set at 2000 μm. The wall was divided into three 
anatomical layers, or ‘tunicas’, namely the intima (150 μm thick), media (200 μm) and adventitia (400 
μm) [13], giving a total wall thickness of 750 μm [14]. To examine the dose distribution within the 
intima in detail, the first 10 μm of this layer was divided into concentric layers of 1 μm thickness. The 
innermost of these layers thus represented the single-cell-thick endothelium of blood vessels. The 
following 10 μm (i.e. 10-20 μm from the lumen edge) was divided into 2 μm layers and the next 30 
μm (20-50 μm from the lumen edge) was divided into 10 μm layers. 
Each layer of the vessel wall was composed of ‘ICRP’ 13-element soft tissue material (density, ρ = 
1.00 g/cm3) obtained from the National Institute of Standards and Technology [15], except for the 
media, which was composed of ICRP muscle (ρ = 1.04 g/cm3) . The lumen was filled with ICRP 13-
element blood material (ρ = 1.06 g/cm3), combined with different mass concentrations of iodine (ρiI) 
(0, 5, 10, 50 and 100 mg I/ml). The density of the blood was adjusted to correspond to ρiI. The vessel 
was placed within a larger soft tissue cylinder of radius 10 cm to simulate electron build-up, scattering 
and beam hardening effects that would occur for vessels located deep within the body. A sensitivity 
analysis was performed by removing the build-up cylinder. Simulations were also repeated with 
different lumen radii (1000 and 4000 μm).  
The second model represented multiple capillaries within a small block of soft tissue (Figure 2). This 
was based around a 25 x 25 lattice of 40 x 40 x 100 μm cuboid elements, each containing a ‘capillary’ 
composed of ICRP blood material, of radius 5 μm and length 100 μm, surrounded by five concentric 1 
μm thick layers of ICRP soft tissue (cells A-E in Figure 2). The innermost of these layers was 
considered representative of the capillary wall. The extravascular remainder of each lattice element 
was also composed of ICRP soft tissue. As with the artery model, the lattice was placed within a soft 
tissue cylinder of radius 10 cm. The model was designed to represent a typical soft tissue with average 
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capillary density. The distance between the edges of adjacent capillary lumens ranged from 30 μm to 
47 μm. Blood made up 5% of the total volume of each lattice element.  
A modified version of the capillary model was also produced, representing a more densely perfused 
tissue (Figure 3). In this model, the lattice elements were reduced in size to 20 x 20 x 100 μm, while 
the capillaries were maintained at the same size. The distance between the edges of adjacent capillary 
lumens in the dense model ranged from 10 μm to 18 μm, with blood making up 20% of the volume of 
each lattice element. Sensitivity analyses were performed by adjusting the density of soft tissue in 
regions B, C, D, E, F and G in the standard capillary model to 0.5 and 2.0 g/cm3 (i.e. half and twice 
the normal density) and changing the composition from soft tissue to adipose (fat, ρ= 0.92 g/cm3) and 
cortical bone (ρ= 1.85 g/cm3). In each case, the composition of the blood and the vessel wall (region 
A) were left unchanged. 
The third model (Figure 4) was designed to simulate situations in which ICM has been given 
sufficient time to diffuse through capillary walls and reach the interstitial medium of a tissue at the 
time of exposure. With the exception of hepatocytes, ICM are not thought to be able to enter cells 
themselves. The interstitial model comprised a 50 x 50 x 50 lattice of cubes, each 11 x 11 x 11 μm in 
size, containing a single cell with a nucleus of radius 7 μm (thus larger than the lattice element, 
creating ‘squircle’-like cell shapes). The remainder of each lattice element (C in figure 4) was water, 
combined with mass concentrations of 0, 1 and 5 mg I/ml of iodine. 
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Figure 1: Cross section of standard artery model. Length of artery is 5 cm. Build-up cylinder 
surrounding vessel not shown. 
 
 
Figure 2: Cross section of a portion of the model representing a network of capillaries in soft 
tissue. Labels A to G correspond to different regions in Table 3. Whole model is a 25 x 25 matrix 
of these elements, each 100 μm long. 
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Figure 3: Cross section of a portion of the dense capillary model. Labels A to F correspond to 
different regions in Table 4. Scale is the same as Figure 2. As with Figure 2, the whole model is a 
25 x 25 matrix of elements, each 100 μm long. 
 
Figure 4: Cross section of model representing cells surrounded by interstitial fluid. Labels A, B and 
C represent cell nuclei, cell remainders and interstitial medium respectively. 
 
 
Monte Carlo simulation methodology: 
We used the general purpose Monte Carlo code MCNP6.1 (Los Alamos National Laboratory, New 
Mexico, USA) [16] for simulations. MCNP has an energy cut-off value of 1 eV. For both the models 
described above, an x-ray source was placed 15 cm away from the centre of the artery/lattice, thus 
outside the build-up cylinder. This irradiated a 4 cm2 region of the artery model and 4 mm2 region of 
the capillary model with a parallel beam of photons, travelling perpendicular to the long axis of the 
artery/central capillary element. Further sensitivity analyses were performed by increasing the size of 
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the beam irradiating the artery model to 25 cm2 (i.e. covering the entire vessel, lengthwise) and 100 
cm2 (i.e. extending beyond the vessel). 
Sufficient photons were tracked to reduce the statistical uncertainties on all of the results from the 
simulations to below 5%. For the artery and interstitial models, simulations were run for 24 hours, 
while 4 hours were sufficient for the capillary model. In both cases, around 100 million particles were 
simulated. MCNP breaks the simulation of electron tracks down into smaller sub-steps. Using the 
default settings, these sub-steps are large compared to the scale of our models. Increasing the ESTEP 
parameter increases the number of sub-steps and decreases their length, thus improving electron 
transport accuracy in small regions. The ESTEP parameter was increased from the default value of 3 
to 2000 for all regions except the build-up cylinder, which was left at 3. 
Beam spectra, representing four clinical applications (two cardiac fluoroscopy and two computed 
tomography), were produced using Spekcalc [17], based on typical values of tube potential and added 
copper (Cu) and aluminium (Al) filtration: 
 Spectrum 1: 120 kV tube potential, 3 mm Al, 0.2 mm Cu, 1st half value layer (HVL) = 7.9 
mm Al (typical of high kV CT). 
 Spectrum 2: 80 kV, 3 mm Al, 0.6 mm Cu, HVL = 7.9 mm Al (low kV CT with high 
filtration).  
 Spectrum 3: 70 kV, 3 mm Al and 0.2 mm Cu added filtration, HVL = 4.9 mm Al 
(paediatric cardiac fluoroscopy digital acquisition). 
 Spectrum 4: 80 kV, 3 mm Al, 0.0 mm Cu, HVL = 3.0 mm Al (adult cardiac fluoroscopy 
digital acquisition). 
Figures showing these beam spectra are presented as supplementary materials for this paper. The 
energy imparted (ε) to the blood itself and each region of the vessel wall, was tallied. Absorbed dose 
was calculated by dividing ε by the mass of the respective cell. The dose enhancement factor 
(DEFICM), presented as percentage increase, was calculated as: 
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𝐷𝐸𝐹𝐼𝐶𝑀  = (
𝐷𝐼 – 𝐷𝑁𝑜 𝐼
𝐷𝑁𝑜 𝐼
) 
Where DI is the absorbed dose in the presence of iodine in the blood and DNo I is the dose in the 
absence of iodine. The number of physical events by photoelectric absorption, Compton scattering 
and generation of knock-on electrons (delta rays) in each region, was also recorded to aid 
interpretation of the results and understanding of the underlying physics.  
 
Results: 
For the artery model, the absorbed dose to the blood itself was increased with the presence of iodine 
(Table 1, Figure 4). Averaged over the four beam spectra, DEFICM was 1.70, 2.38, 7.38 and 12.34, for 
ρiI levels of 5, 10, 50 and 100 mg/ml, respectively. Mean MC simulation uncertainties for the blood 
region were 0.11% (max: 0.15%). Dose was also increased in the vessel wall, albeit to a much smaller 
extent. Within the first micrometre of the wall, i.e. the region representing the endothelium, average 
DEFICM was 1.26, 1.51, 3.48 and 5.56, for the same respective ρiI levels. Mean simulation 
uncertainties for the 1 μm thick layers were 2.37% (max: 3.18%). There was no suggestion of any 
ICM-associated increase in dose outside the media, i.e. >150 μm from the lumen edge. Compared to 
iodine concentration, x-ray beam spectra had relatively little impact (Table 1, Figure 5). The ratio of 
maximum/minimum DEFICM for the four spectra was approximately 2, compared to a factor of over 
10 for different iodine concentrations. The greatest increase in DEFICM to the blood itself was found 
for Spectrum 2 (80 kV, 0.6 mm Cu) while the smallest increase was found for Spectrum 1 (120 kV, 
0.2 mm Cu). These differences probably being caused by the lower photoelectric absorption cross 
section for the higher energy photons and longer ranges of the secondary electrons produced. Beyond 
around 8 μm from the lumen edge, Spectrum 1 tended to yield a marginally higher DEFICM than the 
other three spectra, also confirming the greater average range of secondary electrons produced in 
interactions with iodine. Results using the modified versions of the artery model are shown in Figure 
6 and Table 2 for Spectrum 1.  The impact of various modifications to the artery model are shown in 
Table 2 and Figure 6. The narrow lumen, wide lumen, no build-up, 25 cm2 beam and 100 cm2 beam 
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modifications resulted in 1%, -3%, 0%, 1% and 1% changes to DEFICM  respectively, compared to the 
original model, with these differences approximately maintained at each distance from the lumen 
edge.
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Table 1: Dose enhancement factors for different blood concentrations of iodine relative to no iodine for artery model. *Excluding endothelium. 
Blood vessel 
region 
Distance from 
lumen edge (μm) 
Iodine concentration in blood (mg/ml) 
5.0 10.0 50.0 100.0 
Spectrum Spectrum Spectrum Spectrum 
1 2 3 4 1 2 3 4 1 2 3 4 1 2 3 4 
Lumen Intraluminal 1.63 1.74 1.73 1.67 2.26 2.48 2.45 2.32 6.94 7.92 7.62 7.03 11.83 13.52 12.49 11.50 
Endothelium 0-1 1.26 1.30 1.30 1.17 1.50 1.60 1.52 1.41 3.40 3.85 3.43 3.23 5.44 6.19 5.51 5.11 
Tunica intima* 
(detail) 
1-2 1.22 1.26 1.27 1.19 1.46 1.51 1.46 1.42 3.04 3.50 3.04 2.93 4.88 5.37 4.78 4.42 
2-3 1.19 1.20 1.22 1.17 1.38 1.41 1.38 1.38 2.79 2.99 2.66 2.68 4.26 4.55 4.12 3.88 
3-4 1.18 1.20 1.16 1.13 1.31 1.36 1.34 1.29 2.61 2.70 2.42 2.41 3.92 4.02 3.47 3.44 
4-5 1.12 1.13 1.16 1.14 1.29 1.30 1.29 1.26 2.33 2.38 2.24 2.20 3.51 3.40 2.95 3.14 
5-6 1.12 1.10 1.14 1.13 1.28 1.28 1.26 1.27 2.19 2.30 2.13 2.14 3.18 3.18 2.88 2.99 
6-7 1.11 1.13 1.13 1.12 1.24 1.27 1.25 1.21 2.13 2.25 1.98 1.96 3.02 3.02 2.68 2.70 
7-8 1.11 1.12 1.09 1.13 1.25 1.23 1.20 1.22 2.09 2.03 1.85 1.83 2.96 3.00 2.47 2.52 
8-9 1.11 1.09 1.05 1.09 1.21 1.20 1.16 1.16 1.93 1.97 1.77 1.73 2.66 2.68 2.33 2.32 
9-10 1.10 1.06 1.06 1.08 1.21 1.17 1.13 1.11 1.85 1.84 1.67 1.60 2.46 2.52 2.14 2.08 
10-12 1.08 1.06 1.03 1.06 1.19 1.14 1.11 1.10 1.75 1.75 1.51 1.54 2.31 2.33 1.88 1.92 
12-14 1.07 1.05 1.04 1.05 1.17 1.13 1.09 1.09 1.62 1.67 1.45 1.41 2.18 2.12 1.74 1.69 
14-16 1.07 1.04 1.03 1.05 1.14 1.11 1.06 1.08 1.61 1.57 1.36 1.39 1.94 1.93 1.69 1.60 
16-18 1.06 1.04 1.01 1.04 1.13 1.08 1.05 1.03 1.52 1.42 1.30 1.27 1.84 1.70 1.45 1.44 
18-20 1.02 1.02 1.03 1.04 1.11 1.07 1.05 1.05 1.48 1.37 1.26 1.26 1.81 1.65 1.33 1.40 
20-30 1.03 1.02 1.02 1.01 1.05 1.03 1.03 1.02 1.29 1.19 1.13 1.14 1.53 1.38 1.22 1.22 
30-40 1.01 1.00 1.00 1.01 1.02 1.02 1.02 1.02 1.15 1.09 1.05 1.08 1.26 1.16 1.08 1.07 
40-50 1.01 1.00 1.01 1.00 1.03 1.01 1.01 1.01 1.09 1.05 1.06 1.05 1.15 1.10 1.06 1.07 
50-150 1.00 1.00 1.00 1.00 1.01 1.00 1.01 1.01 1.04 1.03 1.03 1.02 1.03 1.02 1.02 1.01 
Tunica Intima * 1-150 1.02 1.01 1.01 1.01 1.04 1.03 1.03 1.03 1.18 1.17 1.13 1.13 1.29 1.27 1.20 1.19 
Tunica media 150-350 1.00 1.01 1.00 1.00 1.01 1.01 1.01 1.01 1.02 1.02 1.01 1.01 1.02 1.03 0.99 1.00 
Tunica adventitia 350-750 1.00 1.00 1.00 1.00 1.00 1.01 1.01 1.00 1.01 1.02 1.01 1.00 1.01 1.02 1.00 0.99 
Mean MC uncertainty 1.6% 1.6% 1.7% 1.7% 1.7% 1.6% 1.7% 1.8% 1.9% 1.9% 2.1% 2.1% 2.1% 2.2% 2.3% 2.3% 
Maximum MC uncertainty 2.2% 2.3% 2.3% 2.5% 2.4% 2.3% 2.4% 2.5% 2.7% 2.7% 3.0% 3.0% 3.0% 3.2% 3.5% 3.4% 
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Figure 5: Dose enhancement factor as a function of distance from the lumen edge of a small 
artery, for four beam spectra. Results represent enhancement at 50 mg I/ml of blood, compared 
to 0 mg I/ml. 
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Table 2: Dose enhancement factors for different modifications of the artery model. Figures are 
for iodine concentrations of 50 mg/ml and spectrum 1. Note, the 2000 μm lumen figures are the 
same as presented in Table 1. 
Blood vessel 
region 
Distance 
from 
lumen 
edge 
(μm) 
Model modification 
Normal Narrow Wide 
No build-
up 
25 cm² 
beam 
100 cm² 
beam 
Lumen 0 6.94 7.08 6.52 6.95 6.99 7.02 
Endothelium 0-1 3.40 3.42 3.29 3.39 3.61 3.35 
Tunica intima 
1-2 3.04 3.12 3.06 3.03 3.00 3.12 
2-3 2.79 2.81 2.68 2.76 2.80 2.76 
3-4 2.61 2.69 2.52 2.50 2.56 2.67 
4-5 2.33 2.48 2.25 2.43 2.46 2.33 
5-6 2.19 2.36 2.17 2.24 2.25 2.41 
6-7 2.13 2.16 1.98 2.07 2.05 2.17 
7-8 2.09 2.04 1.91 1.97 2.00 2.12 
8-9 1.93 1.91 1.85 1.84 1.91 2.01 
9-10 1.85 1.90 1.76 1.78 1.83 1.89 
10-12 1.75 1.77 1.69 1.70 1.84 1.77 
12-14 1.62 1.66 1.60 1.65 1.67 1.59 
14-16 1.61 1.58 1.51 1.54 1.51 1.59 
16-18 1.52 1.50 1.44 1.50 1.52 1.44 
18-20 1.48 1.41 1.41 1.48 1.41 1.38 
20-30 1.29 1.29 1.30 1.31 1.27 1.27 
30-40 1.15 1.17 1.17 1.16 1.14 1.15 
40-50 1.09 1.08 1.08 1.12 1.09 1.08 
50-150 1.04 1.03 1.02 1.03 1.03 1.03 
Tunica Intima 1-150 1.18 1.17 1.16 1.17 1.02 1.02 
Tunica media 150-350 1.02 1.01 1.01 1.02 1.01 1.02 
Tunica adventitia 350-750 1.01 1.01 1.01 1.01 1.17 1.18 
Mean MC uncertainty 1.6% 2.5% 1.6% 2.3% 2.1% 2.4% 
Maximum MC uncertainty 2.2% 3.6% 2.3% 3.2% 3.0% 3.3% 
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Figure 6: Dose enhancement factor for different modifications of the artery model. Conditions 
represent 50 mg/ml iodine concentrations and Spectrum 1 (120 kV, 0.2 mm Cu). *Note: 2000 
μm lumen data are the same as presented in Table 1 for Spectrum 1. 
 
 
Photoelectric absorption in the blood was increased by a factor of 2.98, 5.01, 22.11 and 44.99 for ρiI 
levels of 5, 10, 50 and 100 mg/ml, respectively (Spectrum 1), while the number of Compton scattering 
events was increased by a factor of 1.01, 1.03, 1.10 and 1.18 for the same respective ρiI levels. Knock-
on electrons were increased by a similar extent to the increase in absorbed dose. 
For the capillary model, the DEFICM for the blood was raised to a smaller extent than for the artery 
model (Table 3), averaging 1.31, 1.61, 4.29 and 7.97 across the four spectra. The gradient in DEFICM 
away from the lumen was similar to the artery model, with the enhancement effect falling by around 
65% in the first micrometre. The DEFICM for each lattice element as a whole (blood, capillary wall 
and surrounding tissue) was 86% lower than DEFICM for the blood only. The DEFICM for all 
extravascular tissues (regions B-G in Figure 2) was 48% lower than for the whole element. This 
implies that if ICM are restricted to capillaries, the impact on dose to extravascular tissues is lower 
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than would be suggested by macroscopic organ dose, assuming a homogenous iodine concentration. 
The impact of beam energy was higher than seen for the artery model, with DEFICM being noticeably 
lower for Spectrum 1 than for other spectra for the blood region (Table 3).  
For the dense capillary model, DEFICM for both the blood and the surrounding tissues was higher, 
compared to the standard capillary model (Table 4). For each whole lattice element, DEFICM was 52% 
lower than for the blood only, viz. a smaller difference than for the standard model. Increasing the 
density of surrounding soft tissue in regions B-G of the standard capillary model led to a decrease in 
DEFICM in these regions (Table 5), ranging from -11% in region B to -68% in region G. Decreasing 
density led to an increase in DEFICM, ranging from +14% in region B to +110% in region G (Table 5). 
These findings are consistent with the density of material respectively reducing and increasing the 
range of secondary electrons released in the capillary lumen.  Replacing the soft tissue in regions B-G 
with adipose tissue resulted in a 5% increase in DEFICM to these regions. Replacing with bone resulted 
in a 16% decrease in DEFICM to regions B-G and a 52% decrease in DEFICM to the blood. The 
absorbed dose in the bone is already much higher for these photon energies, making the bone less 
sensitive to effects happening in adjacent blood vessels.
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Table 3: Dose enhancement factors for different blood concentrations of iodine relative to no iodine for capillary model. 
Model region 
(Figure 2) 
Distance from 
lumen edge (μm) 
Iodine concentration in blood (mg/ml) 
5.0 10.0 50.0 100.0 
Spectrum Spectrum Spectrum Spectrum 
1 2 3 4 1 2 3 4 1 2 3 4 1 2 3 4 
Lumen Within 1.21 1.30 1.38 1.33 1.43 1.59 1.74 1.66 3.45 4.29 4.94 4.47 6.20 8.08 9.31 8.29 
A 0-1 1.07 1.11 1.12 1.12 1.17 1.24 1.25 1.22 1.90 2.29 2.35 2.16 2.94 3.76 3.80 3.50 
B 1-2 1.07 1.08 1.08 1.08 1.12 1.15 1.16 1.17 1.69 1.93 1.90 1.84 2.45 2.96 2.89 2.83 
C 2-3 1.04 1.06 1.06 1.05 1.09 1.13 1.12 1.12 1.51 1.70 1.66 1.65 2.15 2.51 2.44 2.38 
D 3-4 1.04 1.05 1.04 1.04 1.08 1.10 1.08 1.10 1.41 1.55 1.50 1.50 1.90 2.18 2.08 2.11 
E 4-5 1.04 1.04 1.03 1.03 1.07 1.09 1.06 1.08 1.34 1.46 1.41 1.42 1.79 1.95 1.91 1.87 
F 5-15 1.02 1.02 1.01 1.02 1.03 1.04 1.04 1.04 1.20 1.22 1.21 1.20 1.44 1.49 1.45 1.42 
G Surrounds 1.01 1.02 1.01 1.01 1.02 1.03 1.02 1.02 1.15 1.15 1.14 1.12 1.34 1.34 1.28 1.24 
A-G + Lumen All 1.03 1.04 1.04 1.04 1.06 1.08 1.09 1.08 1.38 1.48 1.51 1.47 1.89 2.11 2.17 2.06 
A-G All except blood 1.02 1.03 1.02 1.02 1.04 1.05 1.05 1.05 1.24 1.29 1.27 1.26 1.53 1.62 1.57 1.54 
B-G All outside vessel 1.02 1.02 1.02 1.02 1.04 1.05 1.04 1.04 1.22 1.26 1.24 1.24 1.50 1.57 1.52 1.49 
Mean MC uncertainty 1.3% 1.3% 1.4% 1.5% 1.3% 1.3% 1.3% 1.4% 1.1% 1.1% 1.1% 1.2% 0.9% 0.9% 1.0% 1.0% 
Maximum MC uncertainty 2.0% 2.0% 2.1% 2.2% 1.9% 1.9% 2.0% 2.1% 1.5% 1.5% 1.5% 1.6% 1.3% 1.2% 1.3% 1.3% 
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Table 4: Dose enhancement factors for different blood concentrations of iodine relative to no iodine for dense capillary model. 
Model region 
(Figure 3) 
Distance from 
lumen edge (μm) 
Iodine concentration in blood (mg/ml) 
5.0 10.0 50.0 100.0 
Spectrum Spectrum Spectrum Spectrum 
1 2 3 4 1 2 3 4 1 2 3 4 1 2 3 4 
Lumen Within 1.26 1.35 1.44 1.39 1.54 1.71 1.86 1.76 3.86 4.71 5.40 4.84 7.12 8.81 10.20 9.12 
A 0-1 1.16 1.20 1.23 1.18 1.27 1.34 1.40 1.33 2.45 2.74 2.90 2.67 4.09 4.73 4.76 4.49 
B 1-2 1.13 1.16 1.15 1.14 1.23 1.26 1.27 1.23 2.20 2.37 2.36 2.21 3.50 3.96 3.76 3.65 
C 2-3 1.11 1.11 1.13 1.09 1.20 1.23 1.19 1.18 2.01 2.23 2.17 2.09 3.12 3.58 3.38 3.33 
D 3-4 1.10 1.10 1.07 1.11 1.19 1.21 1.17 1.19 1.91 2.10 2.00 2.02 2.93 3.38 3.14 3.10 
E 4-5 1.10 1.10 1.07 1.09 1.15 1.19 1.16 1.15 1.85 2.04 1.91 1.88 2.83 3.19 2.89 2.82 
F Surrounds 1.08 1.10 1.09 1.09 1.15 1.19 1.18 1.18 1.76 1.90 1.85 1.76 2.64 3.02 2.74 2.67 
A-F + Lumen All 1.14 1.17 1.18 1.17 1.27 1.34 1.36 1.33 2.47 2.86 2.98 2.78 4.35 5.26 5.45 5.08 
A-F All except blood 1.11 1.12 1.11 1.11 1.19 1.22 1.21 1.20 1.96 2.16 2.10 2.02 3.05 3.50 3.27 3.17 
B-F All outside vessel 1.10 1.11 1.10 1.10 1.18 1.21 1.19 1.18 1.91 2.09 2.01 1.95 2.93 3.35 3.10 3.02 
Mean MC uncertainty 2.2% 2.3% 2.4% 2.5% 2.2% 2.2% 2.3% 2.4% 1.7% 1.6% 1.7% 1.8% 1.4% 1.3% 1.4% 1.5% 
Maximum MC uncertainty 2.8% 2.8% 2.9% 3.0% 2.6% 2.6% 2.7% 2.8% 2.0% 2.0% 2.1% 2.2% 1.7% 1.6% 1.8% 1.9% 
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Table 5: Impact of replacing soft tissue in regions B to G with high or low density soft tissue, 
adipose and bone. Data are for Spectrum 1 (120 kV, 0.2 mm Cu) and represent percentage dose 
increase at 50 mg of iodine per ml blood. S/T = soft tissue. 
Model region 
(Figure 2) 
Distance from 
lumen edge (μm) 
Model modification 
Normal 
High 
density 
Low 
density Fat Bone 
Normal - 
No build-
up 
Lumen Within 3.45 3.38 3.62 3.83 1.65 3.77 
A 0-1 1.90 1.85 2.03 2.10 1.23 2.04 
B 1-2 1.69 1.61 1.80 1.81 1.16 1.75 
C 2-3 1.51 1.39 1.65 1.63 1.10 1.58 
D 3-4 1.41 1.27 1.61 1.50 1.08 1.47 
E 4-5 1.34 1.20 1.54 1.46 1.06 1.39 
F 5-15 1.20 1.09 1.39 1.25 1.02 1.20 
G Surrounds 1.15 1.05 1.31 1.19 1.01 1.14 
A-G + Lumen All 1.38 1.20 1.69 1.48 1.06 1.41 
A-G All except blood 1.24 1.12 1.43 1.30 1.03 1.25 
B-G All outside vessel 1.22 1.11 1.40 1.28 1.03 1.23 
Mean MC uncertainty 1.1% 0.5% 1.0% 1.2% 1.2% 0.8% 
Maximum MC uncertainty 1.5% 0.6% 1.6% 1.6% 1.6% 1.2% 
 
 
For the model representing cells surrounded by interstitial fluid, the presence of extracellular iodine 
increased dose to cells (Table 6). For an iodine mass concentration of 5 mg/ml, mean DEFICM figures 
for the nuclei and cell remainders were 1.16 and 1.20 respectively. These figures were around 38% 
and 23% lower than the DEFICM for the whole lattice element (1.26). Again, this suggests macroscopic 
organ doses assuming a homogenous distribution of iodine would overestimate ICM-related increase 
in dose to critical structures (i.e. cell nuclei). Decreasing the cell radii to 6 μm, thereby increasing the 
extracellular proportion of each element, increased the nucleus DEFICM by approximately 60% 
compared to the standard interstitial model. 
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Table 6: Dose enhancement factors for model representing cells surrounded by interstitial fluid 
containing 1.0 or 5.0 mg/ml concentrations of iodine. 
Model region (Figure 
4 region) 
Iodine concentration (mg/ml) 
1.0 5.0 
Spectrum Spectrum 
1 2 3 4 1 2 3 4 
Nucleus (A) 1.02 1.03 1.03 1.02 1.14 1.20 1.15 1.15 
Cell remainder (B) 1.04 1.04 1.04 1.03 1.17 1.22 1.21 1.18 
Whole cell (A+B) 1.03 1.04 1.04 1.03 1.17 1.21 1.20 1.18 
Extra-cellular (C) 1.06 1.07 1.08 1.08 1.31 1.40 1.44 1.40 
Whole model (A+B+C) 1.04 1.05 1.05 1.05 1.22 1.28 1.28 1.25 
Mean MC uncertainty 0.8% 0.8% 0.9% 0.9% 0.8% 0.8% 0.8% 0.9% 
Max MC uncertainty 1.2% 1.3% 1.3% 1.4% 1.2% 1.2% 1.2% 1.3% 
 
 
Discussion: 
A small number of dosimetric evaluations of iodinated contrast media in x-ray imaging have been 
published. Jost et al [18] calculated the blood dose enhancement factor due to the presence of iodine, 
based on the ratio of mass attenuation coefficients of blood, and a blood and iodine solution. These 
DEFICM figures were 1.56 and 6.30, for 5 and 50 mg/ml iodine concentrations, respectively (120 kV 
CT beam spectrum). These were reasonably similar to our Monte Carlo-derived DEFICM figures for 
the blood, for Spectrum 1 (the closest match), of 1.63 and 6.94 respectively. Callisen et al [19] 
calculated DEFICM figures of 1.4, 1.8 and 2.9 for ICM concentrations of 1%, 2% and 5%, respectively 
(equivalent to 3.7, 7.4 and 18.5 mg I/ml, based on the iodine content of ICM of 370 g/ml). By linearly 
scaling the results of our study to these iodine concentrations, our equivalent figures were 1.49, 1.98 
and 3.45, for Spectrum 4.  
Three groups of researchers have investigated the impact of ICM on the absorbed dose to tissues other 
than the blood, from diagnostic x-ray procedures [6-10], albeit with very different approaches. Amato 
et al [6, 7] estimated the average concentration of iodine within organs, based on the difference in 
Hounsfield unit (ΔHU) between ICM-enhanced and unenhanced CT scans. These concentrations were 
then incorporated into GEANT 4 Monte Carlo simulations, yielding estimates for ICM-associated 
increases in dose to the liver, kidneys, pancreas/spleen and thyroid of 1.19 1.71, 1.33 and 1.41, 
respectively. A recent study by Sahbaee et al [10] used a pharmacokinetic modelling approach to 
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estimate iodine concentration for a range of abdominal organs, during CT scans. Monte Carlo 
simulations were then used to estimate an ICM-associated increase in organ dose of between 17% and 
54%. The above studies were based on homogeneous iodine distribution within organs. The findings 
are therefore more applicable to late-phase exposures such as venous phase CT. In reality, a truly 
homogenous distribution of iodine throughout tissues is unlikely to occur as ICM do not enter cells 
themselves. Dose enhancement to critical cellular targets (i.e. DNA in extravascular cells) may, 
therefore, be overestimated to some extent. Sahbaee et al [10] did however, perform a simple 
microdosimetric analysis to determine the proportion of electron energy deposited outside blood 
vessels. They reported an ICM-associated increase in ‘biologically relevant’ dose to the kidneys of 
27% while the increase in macroscopic kidney dose was 54%.  
The study by He et al [8] assumed iodine was restricted to a single sphere of water, embedded within 
a larger water sphere, of radius 14 cm, representing the patient. The energy imparted to the ‘contrast 
sphere’ was increased by a factor of 2.38, 2.21 and 1.63 at 10 mg/ml iodine concentrations, for 
contrast sphere diameters of 0.5 cm, 4.0 cm and 16.0 cm (60 keV mono-energetic x-ray beam). The 
overall energy imparted to the whole phantom was almost unchanged, however. The relative increase 
in energy imparted to the smallest contrast sphere was very close to the increase in energy imparted to 
blood in our study of 2.34 (Spectrum 1). 
The dose enhancement factors obtained in the current study were also compared to observed increases 
in blood cell damage foci (lymphocyte γH2AX, dicentrics and survival) reported in serval in vitro 
studies, cf. [18-21]. These damage foci were increased by an average factor of 1.28 for ρiI levels 
between 3.7 and 7.4 mg/ml (range: 0.8-1.7) thus similar to our DEFICM figures in the first 2-3 μm of 
the vessel wall (i.e. 1.17-1.30). It would be expected that lymphocyte damage enhancement would be 
somewhat lower than blood dose enhancement due to the separation between DNA molecules and the 
extracellular environment (ICM does not enter the cells themselves). Lymphocytes have an unusually 
large nucleus, surrounded by a very thin rim of cytoplasm [22], meaning lymphocyte DNA may be 
very close (< 1 μm) to the extracellular environment and ICM molecules. Further research in which 
lymphocytes are explicitly modelled would be useful. 
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As ICM do not appear to increase DNA damage when mixed with blood in the absence of irradiation 
[21, 23, 24], or are pre-irradiated before mixing [23], the observed increase in lymphocyte DNA 
damage appears to be mostly (if not entirely) dosimetric in nature. Iodine greatly increases the 
probability of photoelectric absorption, principally through k-shell interactions, in enhanced 
structures, compared to unenhanced surroundings. ICM-molecules can, therefore, be considered a 
source of photoelectrons and Auger electrons released following this attenuation process. The range 
of these particles depends on their initial kinetic energy, which is in turn defined by the energy of the 
incident photon and the binding energy (ω) of the interacting electron. For diagnostic x-rays below 
120 keV, secondary electron energies following k-shell interactions (ω for iodine = 33.4 keV) are 
unlikely to exceed around 85 keV, with a corresponding linear range in water, in terms of continuous 
slowing down approximation (CSDA), of around 100 μm [25]. Thus, from a purely theoretical 
perspective, the dose enhancement effect of ICM ought to be highly localised, i.e. within 100 μm of 
ICM molecules. The results of the Monte Carlo simulations presented here, which also take into 
account the impact of fluorescence x-rays produced as part of the photoelectric absorption process, 
appear to confirm this. Thus, the presence of ICM in blood vessels with wall thicknesses greater than 
100 μm is unlikely to increase dose to anything other than the blood itself or the vessel wall, 
providing there is no increase in x-ray output. If ICM have reached smaller blood vessels, including 
those of the capillary network, or the interstitial fluid outside of blood vessels, there is potential for 
increased dose to surrounding tissues, including cells prone to malignant transformation. This will 
only happen if ICM are given sufficient time to reach these small blood vessels at the time of 
exposure. Furthermore, our results suggest that the ICM-associated increase in dose to cells 
surrounding blood vessels is likely to be considerably less than for the blood itself. This means risk 
estimates based on assays of circulating blood cells (i.e. lymphocytes) are likely to overestimate the 
impact of ICM on the cancer risks from x-ray exposures. 
There is reasonably strong evidence that ionising radiation exposure increases the risk of 
cardiovascular disease (CVD), including among individuals receiving radiotherapy and those 
occupationally exposed [26, 27]. Significant increases in CVD have been observed down to doses of 
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0.5 Gy, though lower confidence interval limits often include zero [28]. A number of studies have 
estimated the mean absorbed dose to the heart following x-ray guided cardiac catheterizations [29-
32]. Vañó et al [29] estimated that 10-17% of diagnostic and therapeutic cardiac fluoroscopy 
procedures resulted in absorbed doses to the heart of greater than 0.5 Gy. For paediatric procedures, 
estimated cardiac doses may exceed several hundred mGy for a single procedure [30, 31] or up to 2.9 
Gy following multiple procedures [31]. All these studies used the Monte Carlo code PCXMC (STUK, 
Helsinki, Finland) [33], which models all internal organs as a uniform soft tissues and does not allow 
organ composition to be adjusted or allow calculation of dose to substructures within organs. Besides, 
PCXMC does not simulate electrons, and thus assumes x-ray energy is deposited at the exact site of 
interaction [33]. We avoided these issues by using MCNP, which can (if instructed) simulate electrons 
and is not restricted to inbuilt phantom models. 
The endothelium has been identified as a critical target in the pathogenesis of radiation induced CVD 
[28, 34]. This structure, which comprises a single layer of simple squamous cells lining the inside of 
blood vessels and heart (i.e. the endocardium) [22], is now regarded as much more than a simple 
barrier and is recognized as having an important role in many vascular functions [13, 35]. The large 
increase in dose to the endothelium may, therefore, mean ICM-enhanced exposures have a greater 
impact on CVD risk than suggested by macroscopic estimates of absorbed dose to the heart.  
A number of questions remain unresolved. Firstly, there are little data concerning the concentration of 
iodine in blood vessels and interstitial fluids at the time of exposure for clinical examinations. Clinical 
ρiI is likely to be in the range 0-10 mg/ml [9, 10], though potentially up to 50 mg/ml for direct trans-
catheter injections [21]. A second issue is the potential compensatory increase in x-ray output by 
automatic exposure control (AEC) devices following contrast enhancement [5, 11]. There is mixed 
evidence of a difference in CTDI or DLP for CT scans [23, 24, 36], though based on limited sample 
sizes. As CT output is usually based on the unenhanced scout image, an increase in CTDI or DLP 
ought not to be expected.  
In this study, we have assumed only targeted effects of ionisation radiation. So-called bystander 
effects could, potentially, result in damage to cells not traversed by secondary electrons [37]. This 
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could, in theory, mean damage enhancement effects of ICM could extend further than suggested by 
modelling physical processes alone. Although bystander signals may cause DNA damage in 
untraversed cells, the overall impact is currently unknown and therefore difficult to incorporate into 
microdosimetric models. 
Monte Carlo simulation uncertainties were within acceptable limits (i.e. <5%). Systematic ‘B-type’ 
uncertainties are more difficult to assess. These include (1) variation between patient tissue 
composition and the relatively crude models used in this study, and (2) differences between simulated 
radiation transport in MCNP and real particles. The results of sensitivity analyses using different 
blood vessel sizes suggest a relatively minor impact on the dose gradient away from the lumen edge 
(Tables 2). A larger impact was found for changes to soft tissue density and the distance between 
capillaries (Tables 4 and 5). Improved estimates could be obtained by developing more realistic 
models representing specific tissue types such as lungs, thyroid or bone marrow. Of those, 
consideration of the bone marrow may prove particularly challenging, given the additional dose 
enhancement effects arising from the sharp differences in density and effective-Z that occur on the 
microstructure level at the boundaries between the soft marrow and trabecular bone. 
 
Conclusion: 
It has been suggested that iodinated contrast media may increase cancer risks from diagnostic x-ray 
and interventional fluoroscopy exposures. This study suggests that the impact on cells outside of 
blood vessels, including those prone to malignant transformation, is likely to be [perhaps grossly] 
overestimated by assays of blood cell damage and estimates of absorbed dose to the blood, and 
moderately overestimated by macroscopic organ doses. Conversely, the dose to the endothelium of 
blood vessels and the heart may be underestimated by macroscopic doses. This may have 
consequences in terms of the potential for increased risks of radiation-induced health effects such as 
cardiovascular disease resulting from interventional fluoroscopy procedures. 
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